Comparing nebulized colistin with nebulized Amikacin- Fosfomycin as an adjunctive treatment of ventilator associated pneumonia due to multi drug resistant acinetobacter

Phase 2

Recruiting

• Conditions: ventilator associated pneumonia due to multi drug resistant acinetobacter.; Ventilator associated pneumonia; J95.851

• Registration Number: IRCT20171230038142N13
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 March 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patient hospitalization in ICU
Age between 20 and 85
Diagnosis of ventilator pneumonia for the patient
Diagnosis of cholesterol-sensitive Acinetobacter baumannii
Patient satisfaction

Exclusion Criteria

Diagnosis Another concomitant disease
Start treatment of acinetobacter

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mortality rates. Timepoint: After completing the study. Method of measurement: Counting the number of patients.;Duration of response to treatment. Timepoint: After completing the study. Method of measurement: Counting the number of days admitted and the number of patients saved.;CPIS index. Timepoint: Before and after treatment. Method of measurement: questionnaire.